GlaxoSmithKline's CFO on Q3 and Emerging Markets Business

GlaxoSmithKline's CFO, Simon Dingemans, discusses sales growth and strong cash generation in the third quarter, research and development activity, as well as emerging markets and China.

Mnet 115988 Gsk

GlaxoSmithKline's CFO, Simon Dingemans, discusses sales growth and strong cash generation in the third quarter, research and development activity, as well as emerging markets and China.

More in Operations